United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

European Real Estate: A Market Ready To Mobilize

European real estate investors are preparing for more activity in 2026, with an acceptance that macro headwinds are now risk-allocated like any other underwriting consideration.

European Union Real Estate

SR

McDermott Will & Schulte

Trends In Therapeutic Innovation

As we start the new year, we look back at a year of innovations in the life sciences sector.

United Kingdom Healthcare

B

Boult Wade Tennant

UK Clinical Trials Reform: Early Growth Indicators And Key MHRA Guidance

The UK's ambition to strengthen its position as a leading destination for global clinical research is beginning to show results.

United Kingdom Healthcare

AP

Arnold & Porter

Agritech Thymes: Unlocking The Soil Microbiome: Driving Agritech Innovation In The UK

Although much of my professional experience has focused on the human microbiome, I have always had an interest in the soil and plant microbiome.

United Kingdom IP

HL

HGF Ltd

The Antibody Series #1 Quality Characteristics (CQAs) In Antibody Claims: When The Test Method Can Remain Outside The Claim

United Kingdom IP

HL

HGF Ltd

UK Government To Issue Guidance On Industry Payment Transparency

United Kingdom Healthcare

AP

Arnold & Porter

Celltrion And Sandoz Launch Their Aflibercept Biosimilars In Europe

European Union Healthcare

GP

Goodwin Procter LLP

What Will 2026 Hold For Life Sciences And Biopharma?

United Kingdom Commercial

AO

A&O Shearman

European Commission Proposes Simplifying The Rules On EU Medical And In-Vitro Diagnostic Devices

United Kingdom Healthcare

CM

Crowell & Moring LLP

M&C In The News: What's Holding Back UK Life Sciences?

United Kingdom IP

MC

Marks & Clerk

Precision Breeding In England: Navigating The New Regulatory Framework

United Kingdom Healthcare

FH

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Updates Announced To The UK-US Trade Deal See Greater Support For The Pharmaceuticals Sector

United Kingdom International

GW

Gowling WLG

SPC Waiver: No MA? UK Says Ok

United Kingdom IP

PC

Potter Clarkson

Current Life Sciences Insurance Trends And The Imperative For Specialised Coverage

United Kingdom Healthcare

BJ

Browne Jacobson

Beyond The Buzz: What Is Driving Stablecoin Adoption? (Podcast)

United Kingdom Technology

AO

A&O Shearman

New National Minimum Wage Rates For April 2026

United Kingdom Employment

d

didlaw

Employment Winter Newsletter 2025

United Kingdom Employment

TS

Travers Smith LLP

Data Centres: Common Issues And How To Avoid Them (Video)

United Kingdom Real Estate

FE

Fenwick Elliott LLP

What Differences Can Corporates Leverage Between US And UK Capital Markets? (Video)

United Kingdom Finance

BC

Bryan Cave Leighton Paisner

Confidentiality In Clinical Trials: Arbitration As The Preferred Route For Dispute Resolution

In the life sciences sector, clinical trials are the engine of innovation but also a source of risk.

United Kingdom Litigation

BJ

Browne Jacobson

Climate Resilient Crops – Mitigating The Risks Of Climate Change

Global temperatures are reaching unprecedented levels and action is needed to combat the effects of climate change.

United Kingdom Environment

JA

J A Kemp LLP

Cross-border Collaboration In Life Sciences: How To Make It Work

In an era where health challenges transcend borders, cross-border collaboration in life sciences is no longer a nice to have –it's a necessity.

Worldwide Healthcare

BJ

Browne Jacobson

Unlocking Value Creation In Healthcare: How AI Can Reverse Private Equity's Return Challenges - Part 1: HealthTech And Tech-enabled Services

Private equity's investments in healthcare have often struggled to meet expectations. Top-line growth and attractive exit multiples are elusive in a sector weighed down by legacy systems, labor costs, and regulatory...

United Kingdom Healthcare

A

AlixPartners

Hot Topics: Life Sciences - October 2025

United Kingdom Healthcare

AG

Addleshaw Goddard

How MHRA's International Reliance Is Shaping UK Medicine Regulation

United Kingdom Healthcare

BJ

Browne Jacobson

Technology-Enabled Care In The UK: Legal And Technical Developments To Watch

United Kingdom Healthcare

BJ

Browne Jacobson

The Dog That Barks: The UK's CMA Is Proposing Major Reforms To Veterinary Businesses

United Kingdom Healthcare

AP

Arnold & Porter

Arbitrating Innovation: Resolving IP Disputes In The Life Sciences Sector

United Kingdom Healthcare

BJ

Browne Jacobson

The Importance Of AI In The Development Life Sciences

United Kingdom Healthcare

BJ

Browne Jacobson

MHRA And NICE Launch Aligned Approvals Pathway

United Kingdom Healthcare

AP

Arnold & Porter

Biopharma M&A Activity – Strategics Continue To Lead The Way

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Venture Investment In Life Sciences – Activity Update & Outlook (US & Europe)

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

EU Data Act: Is Your Business Ready?

European Union Privacy

AG

Addleshaw Goddard

MHRA And NICE Launch Aligned Approvals Pathway

On 10 October 2025, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence...

United Kingdom Healthcare

AP

Arnold & Porter

Biopharma M&A Activity – Strategics Continue To Lead The Way

As we entered 2025, we were hopeful for a more upbeat year for pharma M&A activity but, with headwinds still swirling, a dramatic change of pace seemed unlikely.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Venture Investment In Life Sciences – Activity Update & Outlook (US & Europe)

Life sciences venture activity levels remained stable in 2024 and total investment value in the sector was up after a two-year period of decline. So far, 2025 paints a varied picture with a strong first quarter performance in terms of both value and volume.

Worldwide Healthcare

KL

Herbert Smith Freehills Kramer LLP

EU Data Act: Is Your Business Ready?

The EU Data Act is now in force, introducing significant new obligations for organisations manufacturing connected products (IoT) and related services, and for cloud service providers providing services (SaaS, PaaS, IaaS)...

European Union Privacy

AG

Addleshaw Goddard

AI In Medical Devices: Patent Eligibility

United Kingdom IP

MC

Marks & Clerk

Supporting Growth - What Does The UK's Industrial Strategy Mean For Infrastructure?

The return of the UK Industrial Strategy (UKIS) the last edition of which was published by Theresa May's Government in 2017, represents a "statement of intent" by the UK Government of the areas where it will seek...

United Kingdom Energy

GW

Gowling WLG

Life After Separation: What The Future Holds For Pharma Companies And Their Divested Consumer Healthcare Divisions

In recent years, many of the world's biggest pharmaceutical companies have carved out and spun off their consumer health divisions in an effort to refocus on core strategic areas and free up cash for investment

United Kingdom Healthcare

AO

A&O Shearman

Immigration And The UK's Industrial Vision

In today's global economy, competition to attract the most desirable talent is fierce with many countries seeking to improve their attractiveness.

United Kingdom Immigration

LS

Lewis Silkin

AI In The Healthcare Sphere: Public And Private Considerations

Healthcare and legal professionals dealing with medical negligence need to be aware of these issues as they navigate claims involving AI.

United Kingdom Technology

BJ

Browne Jacobson

European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance

European Union Healthcare

GP

Goodwin Procter LLP

Hot Topics: Life Sciences

United Kingdom Healthcare

AG

Addleshaw Goddard

Neurotech Patents In Europe: Methods, Medical Devices, And The EPC Exclusion

United Kingdom IP

MC

Marks & Clerk

The Thursday Investment Club: The Case For Later Living

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

United Kingdom Healthcare

AP

Arnold & Porter

UK Proposes Early Access Service For Innovative Medical Devices

United Kingdom Healthcare

AP

Arnold & Porter

EU Regulatory Reform For Medicinal Products: Bolar Exemption

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Watch What The Federal Government Does, Not What It Says, About Artificial Intelligence

United Kingdom Technology

IG

IR Global

See more

Latest Videos

See more

Working For And With The European Medicines Agency (EMA) (Video)

AP

Arnold & Porter

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

Webinar: Supplementary Protection Certificates - Part Two (Video)

D

Dehns

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

Measuring The Return From Pharmaceutical Innovation 2012 (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More